Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Aparna Parikh
9
Mins
April 2024
Once I got into fellowship, and started to see a lot of GI patients, I found a tremendous affinity towards this patient population…
Read more
10
Mins
5th December 2023
Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and
ROS1
Tyrosine Kinase Inhibitors
The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…
10
Mins
5th December 2023
Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer
The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…
3
Mins
5th December 2023
Isolated Tumour Cells in Early Endometrial Carcinomas
Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…
15
Mins
5th December 2023
Improving Inclusivity and Diversity in Clinical Trials
Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…
6
Mins
5th December 2023
Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer
Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…
12
Mins
1st December 2023
Food Insecurity Among Patients with Cancer
This paper explores the overlooked influence of food insecurity on cancer care, its correlation with malnutrition and poor patient…
10
Mins
8th November 2023
Disparities in the Incidence and Outcome of Endometrial Cancer: Interviews with Two Key Opinion Leaders
Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and often presents with comorbidities…
6
Mins
8th November 2023
Interview: John Marshall
You have to remember that I am a very old oncologist. So, when I first started, there was almost nothing in the world of GI cancer. I was…
Loading posts...
« Previous
1
2
3
4
…
26
Next »